Glioblastoma Research Organization Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2019 | 60,882 | 2,968 | 57,914 | 234.2 | — |
| 2020 | 124,082 | 111,728 | 12,354 | 7.5 | — |
| 2021 | 191,134 | 148,124 | 43,010 | 9.2 | — |
| 2022 | 281,490 | 260,309 | 21,181 | 6.2 | 27% |
| 2023 | 832,005 | 480,261 | 351,744 | 12.1 | 27% |
In its most recent public year (2023), this organization brought in $351,744 more than it spent. Its reserves stood at about 12.1 months of spending, down from 234.2 in 2019. Staff pay was 27% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Glioblastoma Research Organization Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works